药剂师主导干预对2型糖尿病患者糖尿病困扰的影响
Katelyn A Parsons1, Gladys J Ekong1, Maria S Charbonneau1
1Western New England University College of Pharmacy and Health Sciences, Springfield, Massachusetts.
The science of diabetes self-management and care
|August 12, 2024
概括
药剂师主导的干预措施有效地减少了糖尿病困扰,并改善了2型糖尿病患者的葡萄糖控制. 这突显了药剂师在管理糖尿病护理的情感和身体方面的关键作用.
科学领域:
- 内分泌学 在内分泌学.
- 行为科学 行为科学
- 临床药房 临床药房
背景情况:
- 2型糖尿病 (T2DM) 影响全球数百万人,经常伴随着严重的糖尿病困境.
- 糖尿病困扰会对自我管理和血糖控制产生负面影响,需要有针对性的干预措施.
- 社区护理环境为药剂师带领的支持提供了机会,以应对这些挑战.
研究的目的:
- 评估药剂师主导的关于T2DM患者糖尿病困境和葡萄糖管理的教育干预措施的有效性.
- 评估这些干预措施对情绪负担,饮食条和整体幸福感的影响.
- 为了确定患者对药剂师提供的糖尿病护理的满意度.
主要方法:
- 患有T2DM的成年人被招募到一个由药剂师经营的社区诊所.
- 基线评估包括A1C,人口统计,糖尿病困扰量表 (DDS) 和患者健康问卷-2 (PHQ-2).
- 干预措施是根据DDS分级得分进行量身定制的,重点是ADCES7自我护理行为TM;结果在6个月后重新评估.
主要成果:
- 在基线时,77.4%的参与者经历了糖尿病困扰,情绪负担是最普遍的.
- 在干预后,总体DDS得分,情绪负担,饮食困扰,A1C水平和PHQ-2得分的显著降低.
- 参与者表示对教育干预措施的满意度很高,并提高了自我管理技能.
结论:
- 大多数T2DM患者经历糖尿病困扰,即使有足够的血糖控制.
- 药剂师主导的教育干预显然可以减少糖尿病困扰并改善血糖控制 (A1C).
- 为优化T2DM管理和患者福祉,建议进行糖尿病困境的例行查和由药剂师领导的量身定制教育.
相关概念视频
Diabetes: Management and Pharmacotherapy
247
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
247
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones
185
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
185


